ALS using iPSCs

0:59:32

Probing disease mechanisms in ALS using iPSCs, reprogramming and optogenetic approaches

0:48:59

The Use of Human iPSC-derived Motor Neurons for Translational Research

0:14:18

ALS Disease Modelling with Patient-Derived iPSC - an Interview with Dr Rosa, University of Rome

0:57:49

Using induced pluripotent stem cells as a platform for ALS Dr. Nicholas John Maragakis, M.D

0:35:53

Untangling the convergence of disease mechanisms in ALS using personalized iPSC technologies

1:06:10

Modeling the human brain using induced pluripotent stem cells iPSCs 1

0:04:17

Stem Cell Implications for ALS (Amyotrophic Lateral Sclerosis)

0:33:59

M. Nizzardo - Induced pluripotent stem cells for ALS: in vitro disease model and source of trans...

0:12:48

MND/ALS High Throughput Drug Screening Platform

1:06:10

Modeling the human brain using induced pluripotent stem cells iPSCs

0:00:21

Myocytes derived from C9ORF72 ALS-patient iPSCs had individual fibers contracting randomly

0:02:32

How to study amyotrophic lateral sclerosis (ALS) using patient-derived cells?

0:23:09

Modeling ALS using patient-derived motor neurons and glia

0:01:49

How to Reprogram Cells … and Why that Matters to Patients

0:40:28

Using Stem Cells to Treat Human Disease with Clive Svendsen

0:15:08

Stem Cell Therapy for Amyotrophic Lateral Sclerosis

0:01:24

Stem cell therapy for ALS

0:03:27

Changes in pathological phenotype of C9 ALS iPSC-derived lines after treatment with MO oligomers

0:33:48

2020 Symposium on ALS: Evangelos Kiskinis, PhD - Novel Insights into the Molecular Mechanisms ...

1:14:33

Using Stem Cells to Model and Treat ALS by Dr. Clive Svendsen

1:27:44

Modeling C9ORF72 related FTD/ALS with human induced pluripotent stem cells

0:02:00

Study examines large scale generation of muscle controlling nerve cells from ALS patients

0:04:42

Trends in iPSC Culture

1:09:38

Gene & Cell Therapy ALS Trial: Transplanting stem cells into the motor cortex of patients with ALS